Inhibitory effects of pepstatin A and mefloquine on the growth of Babesia parasites

19Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

We evaluated the inhibitory effects of pepstatin A and mefloquine on the in vitro and in vivo growths of Babesia parasites. The in vitro growth of Babesia bovis, B. bigemina, B. caballi, and B. equi was significantly inhibited (P < 0.05) by micromolar concentrations of pepstatin A (50% inhibitory concentrations = 38.5, 36.5, 17.6, and 18.1 μM, respectively) and mefloquine (50% inhibitory concentrations = 59.7, 56.7, 20.7, and 4 μM, respectively). Furthermore, both reagents either alone at a concentration of 5 mg/kg or in combinations (2.5/2.5 and 5/5 mg/kg) for 10 days significantly inhibited the in vivo growth of B. microti in mice. Mefloquine treatment was highly effective and the combination treatments were less effective than other treatments. Therefore, mefloquine may antagonize the actions of pepstatin A against babesiosis and aspartic proteases may play an important role in the asexual growth cycle of Babesia parasites. Copyright © 2012 by The American Society of Tropical Medicine and Hygiene.

Cite

CITATION STYLE

APA

Munkhjargal, T., AbouLaila, M., Terkawi, M. A., Sivakumar, T., Ichikawa, M., Davaasuren, B., … Igarashi, I. (2012). Inhibitory effects of pepstatin A and mefloquine on the growth of Babesia parasites. American Journal of Tropical Medicine and Hygiene, 87(4), 681–688. https://doi.org/10.4269/ajtmh.2012.12-0218

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free